Cargando…

CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas

The clinicopathological significance of amplification was investigated of the gene encoding cyclin E (CCNE1) and we assessed whether CCNE1 was a potential target in endometrioid endometrial carcinomas. CCNE1 amplification and CCNE1 or F-box and WD repeat domain-containing 7 (FBXW7) expression in end...

Descripción completa

Detalles Bibliográficos
Autores principales:	NAKAYAMA, KENTARO, RAHMAN, MOHAMMED TANJIMUR, RAHMAN, MUNMUN, NAKAMURA, KOHEI, ISHIKAWA, MASAKO, KATAGIRI, HIROSHI, SATO, EMI, ISHIBASHI, TOMOKA, IIDA, KOUJI, ISHIKAWA, NORIYUKI, KYO, SATORU
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725452/ https://www.ncbi.nlm.nih.gov/pubmed/26647729 http://dx.doi.org/10.3892/ijo.2015.3268

Ejemplares similares

KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas
por: Rahman, Mohammed Tanjimur, et al.
Publicado: (2013)

Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer
por: Nakayama, Kentaro, et al.
Publicado: (2017)

A Case of Stage III c Ovarian Clear Cell Carcinoma: The Role for Predictive Biomarkers and Targeted Therapies
por: Rahman, Munmun, et al.
Publicado: (2013)

Genetic analysis and phosphoinositide 3-kinase/protein kinase B signaling pathway status in ovarian endometrioid borderline tumor samples
por: Nakamura, Kohei, et al.
Publicado: (2018)

Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas
por: KATAGIRI, HIROSHI, et al.
Publicado: (2015)

Letrozole as second-line hormonal treatment for recurrent low-grade endometrial stromal sarcoma: A case report and review of the literature
por: Nakamura, Kohei, et al.
Publicado: (2016)

Efficacy of microwave ablation for the treatment of endometrial carcinoma: A report of 3 cases
por: NAKAMURA, KOHEI, et al.
Publicado: (2016)

KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions
por: Nakamura, Kohei, et al.
Publicado: (2016)

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
por: Sato, Emi, et al.
Publicado: (2018)

Ovarian Endometrioid and Clear Cell Carcinomas with Low Prevalence of Microsatellite Instability: A Unique Subset of Ovarian Carcinomas Could Benefit from Combination Therapy with Immune Checkpoint Inhibitors and Other Anticancer Agents
por: Nonomura, Yuki, et al.
Publicado: (2022)

High PD-1 expression level is associated with an unfavorable prognosis in patients with cervical adenocarcinoma
por: Ishikawa, Masako, et al.
Publicado: (2020)

Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer
por: Yamashita, Hitomi, et al.
Publicado: (2017)

Mucinous borderline ovarian tumors with BRAF(V600E) mutation may have low risk for progression to invasive carcinomas
por: Ohnishi, Kaori, et al.
Publicado: (2020)

The diagnostic utility of PAX8 immunostaining of malignant peritoneal mesothelioma presenting as serous ovarian carcinoma: A single-center report of two cases
por: Nakamura, Kohei, et al.
Publicado: (2017)

Long-term outcomes of microwave endometrial ablation for treatment of patients with menorrhagia: A retrospective cohort study
por: Nakamura, Kohei, et al.
Publicado: (2017)

Pathological findings in the endometrium after microwave endometrial ablation
por: Nakayama, Kentaro, et al.
Publicado: (2020)

Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients
por: Ishikawa, Masako, et al.
Publicado: (2018)

P16(INK4A) expression might be associated with a favorable prognosis for cervical adenocarcinoma via dysregulation of the RB pathway
por: Ishikawa, Masako, et al.
Publicado: (2021)

A case with life-threatening uterine bleeding due to postmenopausal uterine arteriovenous malformation
por: Sato, Emi, et al.
Publicado: (2015)

Relationship between Microsatellite Instability, Immune Cells Infiltration, and Expression of Immune Checkpoint Molecules in Ovarian Carcinoma: Immunotherapeutic Strategies for the Future
por: Yamashita, Hitomi, et al.
Publicado: (2019)

High Frequency of PIK3CA Mutations in Low-Grade Serous Ovarian Carcinomas of Japanese Patients
por: Ishibashi, Tomoka, et al.
Publicado: (2019)

The Case of an Endometrial Cancer Patient with Breast Cancer Who Has Achieved Long-Term Survival via Letrozole Monotherapy
por: Ishikawa, Masako, et al.
Publicado: (2023)

Establishment of a Novel In Vitro Model of Endometriosis with Oncogenic KRAS and PIK3CA Mutations for Understanding the Underlying Biology and Molecular Pathogenesis
por: Hossain, Mohammad Mahmud, et al.
Publicado: (2021)

Frequent PIK3CA mutation in normal endometrial gland drives spheroid formation and may be involved in stem cell propagation
por: Sato, Seiya, et al.
Publicado: (2023)

Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)
por: Ono, Ruriko, et al.
Publicado: (2019)

Identifying the Carcinogenic Mechanism of Malignant Struma Ovarii Using Whole-Exome Sequencing and DNA Methylation Analysis
por: Yamashita, Hitomi, et al.
Publicado: (2023)

Pregnancy by Assisted Reproductive Technology Is Associated with Shorter Telomere Length in Neonates
por: Minamoto, Toshiko, et al.
Publicado: (2020)

Prognostic Value of Peripheral Blood Lymphocyte Telomere Length in Gynecologic Malignant Tumors
por: Shanta, Kamrunnahar, et al.
Publicado: (2020)

Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status
por: Sawada, Kiyoka, et al.
Publicado: (2023)

High preoperative Glasgow prognostic score is a negative prognostic factor for patients with endometrial carcinoma
por: Nakamura, Kohei, et al.
Publicado: (2018)

Metastasis of breast cancer to an endometrial polyp, the cervix and a leiomyoma: A case report and review of the literature
por: Razia, Sultana, et al.
Publicado: (2017)

Total laparoscopic hysterectomy for large uterine cervical myoma
por: Nakayama, Kentaro, et al.
Publicado: (2017)

Clinical Outcomes of Genotype-Matched Therapy for Recurrent Gynecological Cancers: A Single Institutional Experience
por: Sawada, Kiyoka, et al.
Publicado: (2021)

Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome Resistance
por: Kyo, Satoru, et al.
Publicado: (2022)

Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study
por: Razia, Sultana, et al.
Publicado: (2023)

Mutation Profiles of Ovarian Seromucinous Borderline Tumors in Japanese Patients
por: Sasamori, Hiroki, et al.
Publicado: (2022)

Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma
por: Nakamura, Kohei, et al.
Publicado: (2018)

EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target
por: Iida, K, et al.
Publicado: (2011)

Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas
por: Rahman, M T, et al.
Publicado: (2012)

Underdiagnosis of early cervical cancer with an invisible cervical transformation zone in an elderly patient: A case report
por: Ishikawa, Masako, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2ob34bn40tgu7anjv10i767mp9